browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
2e772a20-fb1d-481d-bfdd-3772e1b61812
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 19:31:21
Income (reported)
Expenses (reported)
$60,000
Expenses method
A
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

ALLIANCE FOR AGING RESEARCH

Non-profit healthcare advocacy organization

Contact
ADINA LASSER
Phone
+1 202-688-1249
Address
zip:20006, city:Washington, state:DC, street:1700 K Street NW Suite 740
Client

ALLIANCE FOR AGING RESEARCH

State
DC
Country
US
Government-entity client
false
Effective date
2015-05-04
Issues lobbied + lobbyists (3)

HCR — Health Issues

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants

Lobbyists:
  • ms ADINA ROSE LASSER [new]
  • SCOTT FREY — covered position: Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy

Government entities lobbied: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

MMM — Medicare/Medicaid

-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -Implementation of the Medicare Direct Negotiation Program and its impact on older adults -Utilization management reform in Medicare -Increasing Medication Access for Seniors Act (H.R.6401)

Lobbyists:
  • ms ADINA ROSE LASSER
  • SCOTT FREY — covered position: Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy [new]

Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

BUD — Budget/Appropriations

-FY27 report language for the Food and Drug Administration on antipsychotics black box warning -FY27 report language for the Medicare Program antipsychotics measure -FY27 report language for the Medicare Prescription Payment Plan -FY27 report language for utilization management reform in the Medicare program -FY27 medical research funding -FY27 funding for FDA's Neurology Drug Program

Lobbyists:
  • ms ADINA ROSE LASSER
  • SCOTT FREY — covered position: Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.